AXIOM INTERESTING THAT ONCE THE DISTRIBUTOR GOT CALYPTE APPROVED IN INDIA THAT CALYPTE'S RESPONSE WAS TO DUMP THE DISTRIBUTOR FOR A BIGGER AND BETTER DISTRIBUTOR. REALLY CONFIDENCE INSPIRING TO DEAL WITH CALYPTE ISN'T IT.
IN ADDITION IT APPEARS THERE IS TROUBLE IN RUSSIA. RAPID ORAL APPROVED IN RUSSIA BUT RUSSIA WON'T LET THEM SELL IT? WHAT DOES THAT MEAN?
ALSO
ROGER SAID THAT THE USAID APPROVAL WAS THE FIRST TIME THEY HAD ACCESS TO FUNDS FROM USAID. DID HE FORGET THAT THE RAPID BLOOD TEST HAS BEEN ON THE USAID approved LIST FOR OVER A YEAR. APPARENTLY SO.
Good News is that this interview only cost Calypte $ 280. Much better than the amount they pay CEOcast for their "coverage".